Aortic stenosis natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 41: | Line 41: | ||
==Prognosis== | ==Prognosis== | ||
30% reduction in gradient is expected as the immediate result of surgical intervention. Patient survival after repeat BAV is higher than that of untreated patients. | 30% reduction in gradient is expected as the immediate result of surgical intervention. Patient survival after repeat BAV is higher than that of untreated patients. | ||
===Low Flow Aortic Stenosis=== | |||
If there is a decline in left ventricular function due to systolic dysfunction, there may be only a moderate transvalvular gradient or low flow aortic stenosis. If there is fibrosis of the left ventricle, there may be incomplete recovery after aortic valve replacement. This scenario can also occur among patients in whom there is a history of myocardial infarction: there is insufficient contractility to mount an aortic gradient. | |||
====Definition==== | |||
#An aortic valve areas < 1.0 cm2 | |||
#A left ventricular ejection fraction < 40% | |||
#A mean pressure difference or gradient across the aortic valve of < 30 mm Hg | |||
With a dobutamine infusion, the aortic valve area should increase to > 1.2 cm2, and the mean pressure gradient should rise above 30 mm Hg. If there is a failure to acheive these improvements, early surgical mortality is 32-33%, but it is only 5–7% in those patients who can augment their contractility and gradient. Survival at five years was 88% after surgery if the patient can augment their contractility, but only 10–25% if the patient cannot augment their contractility. | |||
==References== | ==References== | ||
Revision as of 03:08, 10 April 2012
|
Aortic Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
|
Transcatheter Aortic Valve Replacement (TAVR) |
|
Case Studies |
|
Aortic stenosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Aortic stenosis natural history, complications and prognosis |
|
FDA on Aortic stenosis natural history, complications and prognosis |
|
CDC on Aortic stenosis natural history, complications and prognosis |
|
Aortic stenosis natural history, complications and prognosis in the news |
|
Blogs on Aortic stenosis natural history, complications and prognosis |
|
Directions to Hospitals Treating Aortic stenosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Aortic stenosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Mohammed A. Sbeih, M.D. [2]
Overview
Aortic valve stenosis can lead to serious complications if left untreated because it can weaken the heart. If the aortic valve is narrowed, the left ventricle strains to pump the required amount of blood into the aorta and to the rest of the body, the left ventricle becomes hypertrophied to compensate the narrowing of the valve. Eventually these changes weaken the left ventricle and the whole heart.
Aortic valve stenosis can lead to life-threatening heart problems if it has not been managed appropriately.
As with any surgical intervention, surgical therapies for aortic stenosis carry risks and potential for complication. These complications commonly include vascular issues such as vascular complications and mitral valve injury.
Natural History
Aortic stenosis has prolonged latent period during which the morbidity and mortality are very low, there may be no obvious symptoms during this period [1]. The average rate of progression in Aortic stenosis -once moderate stenosis is present- is a decrease in valve area of 0.1 cm2 per year [2]. Also in average; there is an increase in jet velocity of 0.3 m per second per year and an increase in mean pressure gradient of 7 mm Hg per year [3] [4][5]. However, there is individual variability in the rate of progression of aortic stenosis.
The rate of progression of AS can be faster in patients with degenerative calcific disease than in those with congenital or rheumatic disease [6]. Progression to AS may occur in patients with aortic sclerosis, defined as valve thickening without obstruction to ventricular outflow. Regular follow-up should be scheduled for all patients with mild to moderate AS, even for asymptomatic patients.
Impaired platelet function and coagulation abnormalities as decreased levels of Von Willebrand factor can be seen in most patients with severe AS. This resolves after valve replacement procedure. 20% of patients have clinical bleeding, most often epistaxis or ecchymoses [7].
If left untreated for a long time, Aortic stenosis may lead to complications such as angina, syncope, or heart failure. The average survival is 2 to 3 years after the onset of symptoms [8][9][10],there is also a high risk of sudden death, which may occur without prior symptoms [8]. Sudden death is known to occur in less than 1% per year when patients with aortic stenosis are followed up prospectively [11]. Asymptomatic patients are treated conservatively, whereas corrective surgery (Aortic valvotomy or valve replacement) is generally recommended in patients with symptoms due to AS.
Complications
Possible complications for untreated aortic stenosis include:
- Arrhythmias.
- Endocarditis.
- Left-sided heart failure.
- Left ventricular hypertrophy (enlargement) caused by the extra work of pushing blood through the narrowed valve.
- Atrial fibrillation.
- Myocardial infarction.
- Angina.
- Fainting (syncope).
Precautions
People with aortic stenosis of any aetiology are at risk for the development of infection of their stenosed valve, i.e. infective endocarditis. To lessen the chance of developing that serious complication, people with AS are usually advised to take antibiotic prophylaxis around the time of certain dental/medical/surgical procedures. Such procedures may include dental extraction, deep scaling of the teeth, gum surgery, dental implants, treatment of esophageal varices, dilation of esophageal strictures, gastrointestinal surgery where the intestinal mucosa will be disrupted, prostate surgery, urethral stricture dilation, and cystoscopy. Note that routine upper and lower GI endoscopy (i.e. gastroscopy and colonoscopy), with or without biopsy, are not usually considered indications for antibiotic prophylaxis.
Not withstanding the foregoing, the American Heart Association has recently changed its recommendations regarding antibiotic prophylaxis for endocarditis. Specifically, as of 2007, it is recommended that such prophylaxis be limited only to:
- Those with prosthetic heart valves.
- Those with previous episode(s) of endocarditis.
- Those with certain types of congenital heart disease [12].
Since the stenosed aortic valve may limit the heart's output, people with aortic stenosis are at risk of syncope and dangerously low blood pressure should they use any of a number of common medications. Ironically, these same medicines are used to treat a variety of cardiovascular diseases, many of which may co-exist with aortic stenosis. Examples include nitroglycerin, nitrates, ACE inhibitors, terazosin (Hytrin), and hydralazine. Note that all of these substances lead to peripheral vasodilation. Normally, however, in the absence of aortic stenosis, the heart is able to increase its output and thereby offset the effect of the dilated blood vessels. In some cases of aortic stenosis, however, due to the obstruction of blood flow out of the heart caused by the stenosed aortic valve, cardiac output cannot be increased. Low blood pressure or syncope may ensue.
Prognosis
30% reduction in gradient is expected as the immediate result of surgical intervention. Patient survival after repeat BAV is higher than that of untreated patients.
Low Flow Aortic Stenosis
If there is a decline in left ventricular function due to systolic dysfunction, there may be only a moderate transvalvular gradient or low flow aortic stenosis. If there is fibrosis of the left ventricle, there may be incomplete recovery after aortic valve replacement. This scenario can also occur among patients in whom there is a history of myocardial infarction: there is insufficient contractility to mount an aortic gradient.
Definition
- An aortic valve areas < 1.0 cm2
- A left ventricular ejection fraction < 40%
- A mean pressure difference or gradient across the aortic valve of < 30 mm Hg
With a dobutamine infusion, the aortic valve area should increase to > 1.2 cm2, and the mean pressure gradient should rise above 30 mm Hg. If there is a failure to acheive these improvements, early surgical mortality is 32-33%, but it is only 5–7% in those patients who can augment their contractility and gradient. Survival at five years was 88% after surgery if the patient can augment their contractility, but only 10–25% if the patient cannot augment their contractility.
References
- ↑ Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH (1996). "Progression of valvular aortic stenosis in adults: literature review and clinical implications". Am Heart J. 132 (2 Pt 1): 408–17. PMID 8701905.
- ↑ Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA; et al. (2003). "Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography". J Am Soc Echocardiogr. 16 (7): 777–802. doi:10.1016/S0894-7317(03)00335-3. PMID 12835667.
- ↑ Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode RS (1979). "Rate of progression of severity of valvular aortic stenosis in the adult". Am Heart J. 98 (6): 689–700. PMID 495418.
- ↑ Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A (1983). "Rate of progression of severity of valvular aortic stenosis". Acta Med Scand. 213 (1): 51–4. PMID 6829320.
- ↑ Peter M, Hoffmann A, Parker C, Lüscher T, Burckhardt D (1993). "Progression of aortic stenosis. Role of age and concomitant coronary artery disease". Chest. 103 (6): 1715–9. PMID 8404089.
- ↑ Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M; et al. (2000). "Predictors of outcome in severe, asymptomatic aortic stenosis". N Engl J Med. 343 (9): 611–7. doi:10.1056/NEJM200008313430903. PMID 10965007.
- ↑ Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F; et al. (2003). "Acquired von Willebrand syndrome in aortic stenosis". N Engl J Med. 349 (4): 343–9. doi:10.1056/NEJMoa022831. PMID 12878741.
- ↑ 8.0 8.1 Ross J, Braunwald E (1968). "Aortic stenosis". Circulation. 38 (1 Suppl): 61–7. PMID 4894151.
- ↑ Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS (1988). "Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis". Am J Cardiol. 61 (1): 123–30. PMID 3337000.
- ↑ Iivanainen AM, Lindroos M, Tilvis R, Heikkilä J, Kupari M (1996). "Natural history of aortic valve stenosis of varying severity in the elderly". Am J Cardiol. 78 (1): 97–101. PMID 8712130.
- ↑ Chizner MA, Pearle DL, deLeon AC (1980). "The natural history of aortic stenosis in adults". Am Heart J. 99 (4): 419–24. PMID 7189084.
- ↑ http://www.americanheart.org/presenter.jhtml?identifier=4436